Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1126 to 1140 of 1300 results for heart OR cardi* OR arrythmia

  1. Embolism and thrombosis: mortality rates from VTE (IND61)

    This indicator covers mortality rates directly associated with VTE. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG80

    Network / system level indicators
    Last updated
    22 March 2024

  2. Hypertension: confirming diagnosis with HBPM or ABPM (IND115)

    This indicator covers the percentage of patients with a new diagnosis of hypertension (diagnosed on or after 1 April 2014) which has been confirmed by ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) in the 3 months before entering on to the register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM66

    General practice indicators suitable for use in QOF
    Last updated
    4 November 2020

  3. Is the application of antiseptics and antibiotics in the operative field before wound closure, clinically and cost effective in reducing surgical site infection rates?

    such as vancomycin, which is widely used worldwide and commonly used in cardiac, orthopaedic and spine surgery, suggested no reduction...

    Research recommendation
    Published
    16 August 2019

  4. What is the relative effectiveness and cost effectiveness of different oral fluids and different oral fluid regimens, both with and without oral N-acetylcysteine, at preventing contrast-induced acute kidney injury?

    medium or the healthcare professional offering the procedure, such as a cardiologist, would usually do this. For people with other...

    Research recommendation
    Published
    10 February 2020

  5. Early revascularisation strategy for people with angina and multivessel disease:- In people with stable angina and multivessel disease (including left main stem disease) whose symptoms are controlled with optimal drug treatment, would an initial treatment strategy of revascularisation be clinically and cost effective compared with continued drug treatment?

    have tests to identify whether they have a higher risk profile for early cardiac death, which could be reduced by revascularisation....

    Research recommendation
    Published
    9 June 2015

  6. Is the use of chlorhexidine body wash associated with increased antimicrobial resistance?

    cause of a surgical site infection. The committee agreed that although cardiac and orthopaedic surgery can be considered high risk,...

    Research recommendation
    Published
    16 August 2019

  7. Evidence on the efficacy of bioresorbable stent implantation to treat coronary artery disease is inadequate. Evidence on its safety has shown an increased risk of serious complications in the longer term. This includes an increased risk of myocardial infarction and death with some types of bioresorbable stents. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    implantation to treat coronary artery disease into the National Institute for Cardiovascular Outcomes Research's National Audit of...

    Research recommendation
    Published
    7 September 2022

  8. What is the effectivness of statin treatment in older people?

    effects. Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid modification

    Research recommendation
    Published
    3 May 2024

  9. Automated blood pressure monitoring in people with atrial fibrillation: Which automated blood pressure monitors are suitable for people with hypertension and atrial fibrillation?

    on monitoring treatment and blood pressure targets for people without cardiovascular disease. Full details of the evidence and the...

    Research recommendation
    Published
    11 April 2022

  10. Can risk of contrast-induced acute kidney injury be stratified by eGFR thresholds?

    medium or the healthcare professional offering the procedure, such as a cardiologist, would usually do this. For people with other...

    Research recommendation
    Published
    10 February 2020

  11. What is the most accurate prenatal screening marker for TAPS, including middle cerebral artery peak systolic velocity (MCA‑PSV)?

    umbilical artery and ductus venosus doppler parameters, or signs of fetal cardiac failure in the anaemic baby. These can also occur in a...

    Research recommendation
    Published
    8 November 2019

  12. What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD?

    effects . Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid modification

    Research recommendation
    Published
    3 May 2024

  13. What is the most clinically and cost-effective timing and dose of a single administration of gabapentin to relieve pain in people undergoing surgery whose pain is expected to be moderate to severe?

    fewer side effects from opioid consumption. NSAIDs Concerns about cardiac and renal complications have limited the use of NSAIDs in...

    Research recommendation
    Published
    26 October 2020

  14. What are the implications of FH for the safety of a mother during pregnancy and what are the risks of fetal malformations attributable to pharmacological therapies

    information on the risk of pregnancy (including cardiac death) in a woman with FH. Data on the incidence of cardiac...

    Research recommendation
    Published
    15 November 2019

  15. Premature ovarian insufficiency:- What are the main clinical manifestations of premature ovarian insufficiency and the short- and long-term impact of the most common therapeutic interventions?

    lead to reduced quality of life and an increased risk of osteoporosis, cardiovascular disease and possibly dementia. There is...

    Research recommendation
    Published
    11 December 2015